“Wockhardt surged 9.51% to Rs 320.05 after the company and Serum Life Sciences UK announced collaboration for manufacturing multiple vaccines in the United Kingdom.
Serum Life Sciences UK is a subsidiary of the Serum Institute of India, one of the world's largest vaccine manufacturers to deliver a global vaccine programme.
The collaboration between a subsidiary of Wockhardt and Serum Life Sciences UK will help create considerable number of employment opportunities along with creation of new sterile fill and finish facility in Wrexham, North Wales ('new facility').
A profit sharing arrangement has been made between the two parties for this New Facility that will deliver an additional 150 million vaccin.”